Siddiqi Shirin, Blackstone Eugene H, Bakaeen Faisal G
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland, Ohio.
J Card Surg. 2018 May;33(5):229-234. doi: 10.1111/jocs.13539. Epub 2018 Feb 14.
A variety of cardioplegic solutions are being used widely today to arrest the heart during coronary artery bypass grafting (CABG) and other cardiac operations. To minimize interruptions during the surgery for intermittent dosing of the cardioplegia and to facilitate less invasive cardiac procedures, single-shot solutions, including Bretschneider and del Nido solutions, have been introduced. This review examines the evidence regarding the safety and efficacy of Bretschneider and del Nido cardioplegia during CABG. The findings support their use in routine low-risk CABG, but finds insufficient evidence to support their safety in high-risk surgeries.
如今,在冠状动脉旁路移植术(CABG)和其他心脏手术中,多种心脏停搏液被广泛用于使心脏停搏。为了尽量减少手术期间因间歇性给予心脏停搏液而造成的干扰,并便于开展侵入性较小的心脏手术,已经引入了单次注射型溶液,包括布雷施奈德溶液和德尔尼多溶液。本综述考察了有关布雷施奈德和德尔尼多心脏停搏液在CABG期间的安全性和有效性的证据。研究结果支持它们在常规低风险CABG中的应用,但发现没有足够证据支持它们在高风险手术中的安全性。